Related Experiment Videos
Renal tumor radiofrequency ablation.
1Department of Urology Emory, University Medical Center, Atlanta, GA 30322, USA.
Summary
Radiofrequency ablation (RFA) is an effective minimally invasive treatment for small renal masses, offering a 92% success rate. This heat-based therapy is a valuable option for patients with comorbidities unsuitable for traditional surgery.
Area of Science:
- Urology
- Oncology
- Minimally Invasive Surgery
Background:
- Nephron sparing surgery is standard for small renal tumors (< 4 cm).
- Renal tumor ablation using energy-based modalities is increasingly popular.
- Radiofrequency ablation (RFA) uses heat for cellular destruction.
Purpose of the Study:
- To review the literature on renal RFA applications.
- To assess RFA as a treatment for small renal masses.
Main Methods:
- Comprehensive MEDLINE search (1990-present) for English literature on renal RFA.
- Review of studies on RFA efficacy and application in renal tumors.
Main Results:
- RFA is an effective minimally invasive alternative for small renal masses, especially in patients with comorbidities.
- Limited follow-up data shows a 92% success rate for RFA in treating renal tumors.
- RFA demonstrates short-term efficacy and minimal morbidity.
Conclusions:
- Radiofrequency ablation is a versatile tool for minimally invasive renal cancer treatment.
- RFA offers an encouraging option for patients with small renal tumors and significant comorbidities.
- The technique is effective in destroying renal tumors in situ.